Introduction
This single-centre retrospective study explores demographics and outcomes of patients
who underwent a modified Blalock-Taussig shunt (MBTS) over a 22-year period. The predominant
surgical approach in this study is a lateral thoracotomy, in contrast to a midline
sternotomy. Risks and outcomes of this approach are compared with national and international
literature.
Materials and Methods
Demographic, anatomical, clinical, surgical and outcome data of all patients who underwent
a MBTS between 2000 and 2022 were collected and analysed, excluding Norwood procedures,
which are not performed at this institution. Short- and long-term morbidity and mortality
is described.
Results
Over the 22-year study period, 185 MBTS were performed in 162 patients, at a median
age of 16 days (interquartile range [IQR] 5–59 days) and weight of 3.47 kg (IQR 3–4.25
kg, minimum weight 2 kg). Of these, 79% of patients had a biventricular circulation.
Cardiac diagnoses included both univentricular and biventricular anatomy; tetralogy
of Fallot (TOF) (36%), transposition of the great arteries/ventricular septal defect/pulmonary
stenosis (TGA/VSD/PS) (11%), pulmonary atresia with intact ventricular septum (PA/IVS)
(23%), pulmonary atresia with ventricular septal defect (PA/VSD) (14%), other (16%).
The most common size of MBTS was 4 mm (71%); 93% were performed via a lateral thoracotomy.
There were 47 cases of major operative morbidity, which did not differ significantly
with cardiac diagnosis. Overall all-cause mortality was 13.5%. Early operative mortality
was 4.3%. Mortality varied with cardiac diagnosis, 6% with TOF and 19% with PA/IVS.
There was no era effect on mortality rates, however a lower frequency of major morbidity
(23% vs 7%, p=0.03) was observed in the most recent third of the study period. Risk
factors for shunt reintervention or mortality included weight <2.5 kg (HR=2.79 [1.37,
5.65], p=0.005), and pre- (HR=3.31 [1.86, 5.9], p<0.001) or postoperative lactic acidosis
(HR=1.37 [1.25,1.5], p<0.001). These rates are comparable to those in the literature,
with the predominant approach a midline sternotomy.
Conclusion
Mortality rates and risk factors for adverse outcomes are comparable to those previously
reported for both univentricular and biventricular groups. These results highlight
that outcomes of MBTS performed via lateral thoracotomy are comparable to those by
midline sternotomy as reported in the literature. Operating via the lateral approach
may be advantageous as it avoids the complications of a midline sternotomy.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Heart, Lung and CirculationAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Two thousand Blalock-Taussig shunts: a six-decade experience.Ann Thorac Surg. 2007; 84 (discussion -5): 2070-2075
- Systemic pulmonary shunts in neonates: early clinical outcome and choice of surgical approach.Ann Thorac Surg. 2000; 69: 1499-1504
- Results of palliation with an initial modified Blalock-Taussig shunt in neonates with single ventricle anomalies associated with restrictive pulmonary blood flow.Ann Thorac Surg. 2015; 99 (discussion 46-7): 1639-1646
- Determinants of adverse outcomes after systemic-to-pulmonary shunts in biventricular circulation.Ann Thorac Surg. 2017; 104: 1365-1370
- Team RC. R: A language and environment for statistical computing Vienna, Austria: R Foundation for Statistical Computing; 2022.(Available from:)
- Outcomes of Blalock-Taussig shunts in current era: a single center experience.Congenit Heart Dis. 2017; 12: 808-814
- Risk factors for mortality and morbidity after the neonatal Blalock-Taussig shunt procedure.Ann Thorac Surg. 2011; 92 (discussion 51-2): 642-651
- Factors affecting death and progression towards next stage following modified Blalock-Taussig shunt in neonates.Eur J Cardiothorac Surg. 2016; 50: 169-177
- The Blalock-Taussig shunt revisited: a contemporary experience.J Am Coll Surg. 2013; 216: 699-704
- Disease-specific outcome analysis of palliation with the modified Blalock-Taussig shunt.World J Pediatr Congenit Heart Surg. 2015; 6: 67-74
- Sternotomy approach for the modified Blalock-Taussig shunt.Circulation. 1995; 92: 256-261
- Modified Blalock Taussig shunt: a not-so-simple palliative procedure.Eur J Cardiothorac Surg. 2013; 44: 1096-1102
- Is sternotomy superior to thoracotomy for modified Blalock–Taussig shunt?.Interact Cardiovasc Thorac Surg. 2014; 18: 371-375
- Borrowing from adult cardiac surgeons – bringing congenital heart surgery up to speed in the minimally invasive era.Innovations (Phila). 2020; 15: 101-105
- Surgical approaches to the Blalock shunt: does the approach matter?.Heart Lung Circ. 2010; 19: 460-464
- Modified Blalock-Taussig shunt: use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts.J Thorac Cardiovasc Surg. 1981; 81: 112-119
- Perioperative strategy to minimize mortality in neonatal modified Blalock–Taussig–Thomas shunt: a literature review.Cirugía Cardiovascular. 2022; 29: 31-35
- Blalock–Taussig shunt size: should it be based on body weight or target branch pulmonary artery size?.Pediatr Cardiol. 2019; 40: 38-44
Article info
Publication history
Published online: January 06, 2023
Accepted:
December 7,
2022
Received in revised form:
November 21,
2022
Received:
August 3,
2022
Identification
Copyright
Crown Copyright © 2022 Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). All rights reserved.